You just read:

Goodwin Biotechnology Expands its ADC Capabilities with a High Containment Suite for Development and cGMP Manufacturing of Cytotoxic ADCs

News provided by

Goodwin Biotechnology, Inc.

18 May, 2016, 09:00 ET